Literature DB >> 18337428

Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment.

Peter Flachenecker1, Heike Meissner.   

Abstract

We report on a patient with multiple sclerosis (MS) who presented with fatigue as the only manifestation of an acute MS relapse. Fatigue was assessed by the 'Würzburg Fatigue Inventory in MS (WEIMuS)' scale and confirmed by neuropsychological testing of attention. After high-dose corticosteroid therapy, subjective symptoms were completely abolished. The improvement was corroborated by both, the WEIMuS score and neuropsychological testing. MS-related fatigue may be the only symptom of an acute MS relapse, and neuropsychological methods may be used to objectively assess and follow the time course of this common and disabling symptom.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337428     DOI: 10.1177/1352458507082480

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Dynamics of saccade parameters in multiple sclerosis patients with fatigue.

Authors:  Carsten Finke; Luisa Maria Pech; Carina Sömmer; Jeremias Schlichting; Sarah Stricker; Matthias Endres; Florian Ostendorf; Christoph J Ploner; Alexander U Brandt; Friedemann Paul
Journal:  J Neurol       Date:  2012-06-19       Impact factor: 4.849

2.  Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).

Authors:  Uwe K Zettl; Thomas Henze; Ute Essner; Peter Flachenecker
Journal:  Eur J Health Econ       Date:  2013-12-01

3.  Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study.

Authors:  Laura Wieder; Gunnar Gäde; Luisa M Pech; Hanna Zimmermann; Klaus-Dieter Wernecke; Jan-Markus Dörr; Judith Bellmann-Strobl; Friedemann Paul; Alexander U Brandt
Journal:  BMC Neurol       Date:  2013-11-08       Impact factor: 2.474

4.  Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.

Authors:  Philippe Manceau; Clotilde Latarche; Sophie Pittion; Gilles Edan; Jérôme de Sèze; Catherine Massart; Marc Debouverie
Journal:  BMC Neurol       Date:  2014-11-30       Impact factor: 2.474

Review 5.  The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue.

Authors:  Christian Veauthier; Helge Hasselmann; Stefan M Gold; Friedemann Paul
Journal:  EPMA J       Date:  2016-11-24       Impact factor: 6.543

6.  Oculomotor Fatigue and Neuropsychological Assessments mirror Multiple Sclerosis Fatigue.

Authors:  Wolfgang H Zangemeister; Christof Heesen; Dorit Röhr; Stefan M Gold
Journal:  J Eye Mov Res       Date:  2020-09-13       Impact factor: 0.957

7.  Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.

Authors:  J H Faiss; D Dähne; K Baum; R Deppe; F Hoffmann; W Köhler; A Kunkel; A Lux; M Matzke; I K Penner; M Sailer; U K Zettl
Journal:  BMJ Open       Date:  2014-04-10       Impact factor: 2.692

8.  Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in Germany.

Authors:  Thomas Henze; Sylvia von Mackensen; Gerald Lehrieder; Uwe K Zettl; Carmen Pfiffner; Peter Flachenecker
Journal:  Health Qual Life Outcomes       Date:  2014-08-01       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.